349 related articles for article (PubMed ID: 26024921)
1. Social marketing of low dead space syringes in Vietnam: findings from a 1-year pilot program in Hanoi, Thai Nguyen, and Ho Chi Minh City.
Huong NT; Mundy G; Neukom J; Zule W; Tuan NM; Tam NM
Harm Reduct J; 2015 May; 12():15. PubMed ID: 26024921
[TBL] [Abstract][Full Text] [Related]
2. Low dead-space syringes for preventing HIV among people who inject drugs: promise and barriers.
Zule WA
Curr Opin HIV AIDS; 2012 Jul; 7(4):369-75. PubMed ID: 22627710
[TBL] [Abstract][Full Text] [Related]
3. Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation.
Hancock E; Ward Z; Ayres R; Neale J; Hussey D; Kesten JM; Hickman M; Vickerman P
Addiction; 2020 Apr; 115(4):702-713. PubMed ID: 31633849
[TBL] [Abstract][Full Text] [Related]
4. Acceptability of low dead space syringes and implications for their introduction: A qualitative study in the West of England.
Kesten JM; Ayres R; Neale J; Clark J; Vickerman P; Hickman M; Redwood S
Int J Drug Policy; 2017 Jan; 39():99-108. PubMed ID: 27788406
[TBL] [Abstract][Full Text] [Related]
5. Factors that influence the characteristics of needles and syringes used by people who inject drugs in Tajikistan.
Zule WA; Latypov A; Otiashvili D; Kirtadze I; Ibragimov U; Bobashev GV
Harm Reduct J; 2015 Oct; 12():37. PubMed ID: 26472669
[TBL] [Abstract][Full Text] [Related]
6. Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UK.
Trickey A; May MT; Hope V; Ward Z; Desai M; Heinsbroek E; Hickman M; Vickerman P
Drug Alcohol Depend; 2018 Nov; 192():118-124. PubMed ID: 30245460
[TBL] [Abstract][Full Text] [Related]
7. Could low dead-space syringes really reduce HIV transmission to low levels?
Vickerman P; Martin NK; Hickman M
Int J Drug Policy; 2013 Jan; 24(1):8-14. PubMed ID: 23206493
[TBL] [Abstract][Full Text] [Related]
8. Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA.
Siddiqui SS; Armenta RF; Evans JL; Yu M; Cuevas-Mota J; Page K; Davidson P; Garfein RS
Int J Drug Policy; 2015 Nov; 26(11):1150-7. PubMed ID: 26252980
[TBL] [Abstract][Full Text] [Related]
9. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
Kim NJ; Jin H; McFarland W; Raymond HF
Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
Zhang L; Celentano DD; Le Minh N; Latkin CA; Mehta SH; Frangakis C; Ha TV; Mo TT; Sripaipan T; Davis WW; Quan VM; Go VF
Eur J Gastroenterol Hepatol; 2015 May; 27(5):550-6. PubMed ID: 25769097
[TBL] [Abstract][Full Text] [Related]
11. Sharing of Needles and Syringes among Men Who Inject Drugs: HIV Risk in Northwest Bangladesh.
Pasa MK; Alom KR; Bashri Z; Vermund SH
PLoS One; 2016; 11(2):e0148276. PubMed ID: 26848756
[TBL] [Abstract][Full Text] [Related]
12. Modeling the effect of high dead-space syringes on the human immunodeficiency virus (HIV) epidemic among injecting drug users.
Bobashev GV; Zule WA
Addiction; 2010 Aug; 105(8):1439-47. PubMed ID: 20528817
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.
Zlotorzynska M; Weidle PJ; Paz-Bailey G; Broz D;
Int J Drug Policy; 2018 Dec; 62():51-58. PubMed ID: 30359873
[TBL] [Abstract][Full Text] [Related]
14. Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries.
Zule WA; Cross HE; Stover J; Pretorius C
Int J Drug Policy; 2013 Jan; 24(1):1-7. PubMed ID: 22884539
[TBL] [Abstract][Full Text] [Related]
15. Using Pharmacies in a Structural Intervention to Distribute Low Dead Space Syringes to Reduce HIV and HCV Transmission in People Who Inject Drugs.
Oramasionwu CU; Johnson TL; Zule WA; Carda-Auten J; Golin CE
Am J Public Health; 2015 Jun; 105(6):1066-71. PubMed ID: 25880955
[TBL] [Abstract][Full Text] [Related]
16. Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016.
Kwon JA; Iversen J; Law M; Dolan K; Wand H; Maher L
Drug Alcohol Depend; 2019 Apr; 197():108-114. PubMed ID: 30802734
[TBL] [Abstract][Full Text] [Related]
17. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England.
Romo E; Rudolph AE; Stopka TJ; Wang B; Jesdale BM; Friedmann PD
Addict Sci Clin Pract; 2023 Jan; 18(1):2. PubMed ID: 36597153
[TBL] [Abstract][Full Text] [Related]
18. The Effectiveness of Low Dead Space Syringes for Reducing the Risk of Hepatitis C Virus Acquisition Among People Who Inject Drugs: Findings From a National Survey in England, Wales, and Northern Ireland.
Trickey A; Croxford S; Emanuel E; Ijaz S; Hickman M; Kesten J; Thomas C; Edmundson C; Desai M; Vickerman P
Clin Infect Dis; 2022 Sep; 75(6):1073-1077. PubMed ID: 35184173
[TBL] [Abstract][Full Text] [Related]
19. Co-design of harm reduction materials for people who inject drugs to implement research findings.
Hussey D; Trinder-Widdess Z; Dee C; Bagnall D; Bojangles T; Kesten JM
Harm Reduct J; 2019 Jun; 16(1):36. PubMed ID: 31174536
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and correlates of HIV infection among men who inject drugs in a remote area of Vietnam.
Nghiem VT; Bui TC; Nadol PP; Phan SH; Kieu BT; Kling R; Hammett TM
Harm Reduct J; 2018 Feb; 15(1):8. PubMed ID: 29444685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
